Leukemia, B-Cell, Chronic (DBCOND0030746)
Identifiers
- Synonyms
- Chronic B-Cell Leukemia / B-Cell Leukemia, Chronic / Chronic Leukemia, B-Cell / Chronic lymphocytic leukemia of B-cell type not having achieved remission / Chronic lymphocytic leukemia of B-cell type / B-cell chronic lymphocytic leukaemia / B-cell chronic lymphocytic leukemia / Chronic lymphocytic leukemia / Leukemia lymphocytic chronic / CLL / Chronic lymphoid leukaemia / Lymphoid leukaemia, chronic / Chronic lymphoid leukemia, disease (disorder) / Lymphoid leukemia, chronic / Chronic lymphatic leukaemia / Chronic lymphoid leukemia / Leukaemia lymphocytic chronic / Chronic lymphatic leukemia / Chronic lymphocytic leukaemia NOS / Leukaemias chronic lymphocytic / Chronic lymphocytic leukaemia / Chronic lymphocytic leukemia, morphology (morphologic abnormality) / Leukemia, Lymphocytic, Chronic, B-Cell
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT02440685 A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors treatment 1 / 2 terminated NCT00546793 Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL treatment 1 / 2 completed NCT00344825 Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL) Not Available Not Available completed NCT00078520 Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells No drug interventions treatment 1 completed NCT00559624 Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients treatment 1 / 2 completed NCT00419250 A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia treatment 1 completed